Switching to aromatase inhibitors in early breast cancer

Lancet. 2007 Feb 17;369(9561):533-5. doi: 10.1016/S0140-6736(07)60201-3.
No abstract available

Publication types

  • Comment

MeSH terms

  • Androstadienes / administration & dosage
  • Androstadienes / therapeutic use*
  • Antineoplastic Agents, Hormonal / administration & dosage
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors / administration & dosage
  • Aromatase Inhibitors / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Drug Administration Schedule
  • Female
  • Humans
  • Randomized Controlled Trials as Topic
  • Survival Rate
  • Tamoxifen / administration & dosage
  • Tamoxifen / therapeutic use*

Substances

  • Androstadienes
  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Tamoxifen
  • exemestane